Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: Trend analysis of WHO mortality database

BMJ (Online)

Volumn 343, Issue 7818, 2011, Pages

  Autier, Philippe ^a   Boniol, Mathieu ^a   Gavin, Anna ^b   Vatten, Lars J ^c  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^b Northern Ireland Cancer Registry   (United Kingdom)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BELGIUM; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; CONTROLLED STUDY; EUROPEAN UNION; FEMALE; HEALTH CARE ACCESS; HEALTH SERVICE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; NORWAY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SWEDEN; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; AGE DISTRIBUTION; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; EARLY DIAGNOSIS; EPIDEMIOLOGY; EUROPE; HEALTH CARE DELIVERY; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OBESITY; PROGNOSIS; STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CAUSE OF DEATH; CONFOUNDING FACTORS (EPIDEMIOLOGY); EARLY DETECTION OF CANCER; EUROPE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MORTALITY; OBESITY; PREVALENCE; PROGNOSIS;

EID: 79961242511     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d4411     Document Type: Article

References (52)

1. Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, Héry C, et al. Disparities in breast cancer mortality trends between thirty European countries: retrospective trend analysis of WHO mortality database. BMJ 2010;341:c3620.
2. Héry C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 2008;19:1187-94. (Pubitemid 351796346)
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
4. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92. (Pubitemid 41549890)
5. Jones AL. Reduction in mortality from breast cancer: screening and increased use of adjuvants are responsible - adjuvants more so. BMJ 2005;330:205-6.
6. International Agency for Research on Cancer. IARC/WHO handbooks of cancer prevention vol 7: breast cancer screening. IARC Press, 2002.
7. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009;45:2640-8.
8. Läärä E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes. Lancet 1987;i:1247-9. (Pubitemid 17070815)
9. International Agency for Research on Cancer. IARC/WHO handbooks of cancer prevention vol 10: cervix cancer screening. IARC Press, 2005.
10. Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Håkansson S. Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 2000;7:14-8. (Pubitemid 30305461)
11. Von Karsa L, Antilla A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer screening in the European Union, report on the implementation of the council recommendation on cancer screening, first report, Directorate General Health and Consumers, European Communities. 2008. http://ec.europa.eu/health/ph- determinants/genetics/documents/cancer-screening.pdf.
12. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45-51.
13. Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P. Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 2007;22:447-55. (Pubitemid 47222954)
14. Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-10.
15. Fracheboud J, Otto SJ, van Dijck JA, Broeders MJ, Verbeek AL, de Koning HJ. Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 2004;91:861-7. (Pubitemid 39273776)
16. National Evaluation Team for Breast Cancer Screening. NETB interim report 2007. Main results of breast cancer screening programme in The Netherlands. NETB, 2007.
17. Vandenbroucke A, Bourdon C. Breast cancer screening programmes - results of studies in foreign countries - situation in Belgium. Eur J Cancer Prev 1993;2:269-74.
18. De Bock C, Fabri V, Remacle A. Succès contrastés du programme de dépistage du cancer du sein. Education Santé, No 246. 2009. [French.] www.educationsante.be/es/article.php?id=1127.
19. Fabri V, Remacle A. Programme de dépistage du cancer du sein: comparaison des trois premiers tours 2001-2002, 2003-2004 et 2005-2006. Rapport numéro 6 de l'Agence Intermutualiste. [French and Dutch.] 2009. www.nic-ima.be/fr.
20. Kee F, Telford AM, Donaghy P, O'Doherty A. Attitude or access: reasons for not attending mammography in Northern Ireland. Eur J Cancer Prev 1992;1:311-5.
21. HSC Public Health Agency. NI cancer screening programmes. 2011. www.cancerscreening.n-i.nhs.uk/statistics/.
22. BreastCheck - The National Breast Screening Programme. Programme report 2008/09. Irish National Cancer Screening Service Ireland, 2009.
23. World Health Organization. Mortality database. 2010. www.who.int/ healthinfo/morttables.
24. ermars 81. 1982. http://economie.fgov.be/fr/binaries/ 01-fr-tcm326-33744.pdf.
25. National Cancer Institute. Joinpoint regression program, version 2.7. 2011. www.srab.cancer.gov/joinpoint/.
26. Barnett GC, Shah S, Redman K, Easton DF, Ponder BAJ, Pharoah PDP. Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 2008;26:3310-6.
27. European Commission. Eurostat database. 2011. http://ec.europa.eu/ eurostat/.
28. Boniol M, Autier P. Prevalence of main cancer lifestyle risk factors in Europe in 2000. Eur J Cancer 2010;46:2534-44.
29. Association of Public Health Observatories. International comparisons of obesity prevalence. National Obesity Observatory, National Health Service (NFS), 2009.
30. Van Bavel J, Bastiaenssen V. De evolutie van de vruchtbaarheid in het Vlaamse Gewest tussen 2001 en 2005. Interface demography working paper:2006-1. 2006. www.vub.ac.be/SOCO/demo/intro.htm.
31. Goed Gevoel. Gezondheid/psycho. [Dutch.] 2011. www.goedgevoel.be/gg/nl/ 449/Geboorte/article/detail/1126704/2010/06/29/Vrouw-nooit-zo-oud-bij-geboorte- eerste-kind.dhtml.
32. Statistics Press Notice. Births in Northern Ireland (2006). Northern Ireland Statistics and Research Agency, 2007.
33. Jonsson B, Wilking N. A global comparison regarding patient access to cancer drugs. Ann Oncol 2007;18(suppl 3):1-74.
34. WHO Statistical Information System. 2011. www.who.int/whosis/.
35. Donnelly DW, Gavin AT, Comber H. Cancer in Ireland 1994-2004: a summary report. 2009. www.qub.ac.uk/nicr.
36. Herman PM, Walsh ME. Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona's comprehensive statewide smoking ban. Am J Public Health 2011;101:491-6.
37. Doll R, Peto R. The causes of cancer. Oxford University Press, 1981.
38. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19. (Pubitemid 34246378)
39. Mathers CD, Ma Fat D, Inoue M, Rao C, Lopez A. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Org 2005;83:171-7. (Pubitemid 40387156)
40. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-8.
41. Anderson I, Nystrom L. Mammography screening. J Natl Cancer Inst 1995;87:1263-4.
42. Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF. Mammography screening: no reliable supporting evidence? Lancet 2002;359:404-6.
43. Broeders MJM, Peer PGM, Straatman H, Beex LVAM, Hendriks JHCL, Holland R, et al. Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and The Netherlands, 1969-1997. Int J Cancer 2001;92:303-8. (Pubitemid 32225385)
44. Autier P, Héry C, Haukka J, Boniol M, Byrnes G. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol 2009;27:5919-23.
45. Autier P, Boniol M, Middleton R, Doré JF, Héry C, Zheng T, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 2011; published online 20 January.
46. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomised trials among 28,896 women. N Engl J Med 1988;319:1681-92.
47. Otten JD, Broeders MJM, Fracheboud J, Otto SJ, de Koning HJ, Verbeek ALM. Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer 2008;123:1929-34.
48. Siebel MF, Muss HB. The influence of aging on the early detection, diagnosis, and treatment of breast cancer. Curr Oncol Rep 2005;7:23-30. (Pubitemid 40277587)
49. Eaker S, Dickman PW, Bergkvist L, Holmberg L. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med 2006;3:e25.
50. Bernardi D, Errante D, Galligioni E, Crivellari D, Bianco A, Salvagno L, et al. Treatment of breast cancer in older women. Acta Oncol 2008;47:187-98.
51. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302:1685-92.
52. Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010;340:c1241.